Presentation Information
[1P-233]Development of the "AlissAID" system degrades target protein using single domain antibodies.
○Yoshitaka Ogawa1, Kohei Nishimura1, Keisuke Obara1, Takumi Kamura1 (1. Nagoya univ.)
Comment
To browse or post comments, you must log in.Log in